Pipeline — registered trials by phase
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
— · Breast Cancer · Completed · est. 2007-12
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Oscar Health is lead sponsor; 1 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13D/A2026-09-18SCHEDULE 13D/A
- 8-K2026-09-16Current report (material event)
- 10-Q2026-08-07Quarterly report
- 8-K2026-08-06Current report (material event)
- 8-K2026-06-09Current report (material event)
- 8-K2026-06-08Current report (material event)
- 8-K2026-06-02Current report (material event)
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-06Current report (material event)
- ARS2026-04-22Annual report to holders
- DEFA14A2026-04-22DEFA14A
- DEF 14A2026-04-22Proxy statement
- 8-K2026-04-21Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-02Current report (material event)
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- S-82026-02-13Employee stock plan
- 10-K2026-02-13Annual report
- 8-K2026-02-10Current report (material event)
- 8-K2025-12-29Current report (material event)
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- 8-K2025-09-18Current report (material event)
- 8-K2025-09-16Current report (material event)
- 8-K2025-09-15Current report (material event)
- 8-K2025-09-03Current report (material event)
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-06Current report (material event)
- SCHEDULE 13G/A2025-07-31SCHEDULE 13G/A
- 8-K2025-07-22Current report (material event)
- SCHEDULE 13G/A2025-07-17SCHEDULE 13G/A
- 8-K2025-06-06Current report (material event)
- 10-Q2025-05-08Quarterly report
- 8-K2025-05-07Current report (material event)
- SCHEDULE 13G2025-04-29SCHEDULE 13G
- ARS2025-04-25Annual report to holders
- DEFA14A2025-04-25DEFA14A
- DEF 14A2025-04-25Proxy statement
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.